27 results
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
14 Dec 23
Current report (foreign)
6:01am
Code of Conduct, global policies (prohibition of bribery, handling of personal information, prohibition of insider trading, etc.) and other compliance
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
12 Jul 23
Current report (foreign)
6:07am
of bribery, handling of personal information, prohibition of insider trading, etc.) and other compliance-related internal rules, and implements training
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
23 Jun 23
Current report (foreign)
6:13am
(prohibition of bribery, handling of personal information, prohibition of insider trading, etc.) and other compliance-related internal rules
6-K
EX-99.1
5z7ign
30 May 23
Current report (foreign)
6:11am
6-K
EX-99.1
6245mw6
17 Dec 20
Current report (foreign)
6:01am
F-3ASR
EX-1.1
wt03prfl7hes
24 Jun 20
Automatic shelf registration (foreign)
4:30pm
6-K
EX-99.1
1rzaehjz5 vw8viiwd
10 Jan 20
Better Health, Brighter Future 2019 SUSTAINABLE VALUE REPORT Takeda Pharmaceutical Company Limited
6:36am
424B3
arvan4hu
14 Nov 19
Prospectus supplement
6:10am
F-4/A
bdl76k 7p
12 Nov 19
Registration of securities (foreign) (amended)
9:50am
F-4
yolx6b clwexsceu1
9 Aug 19
Registration of securities (foreign)
6:27am
20-F
jxmynw6xu3ybv
27 Jun 19
Annual report (foreign)
6:41am
20FR12B/A
EX-10.5
8124qdfb
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
20FR12B/A
EX-10.7
akv5pl
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
20FR12B/A
EX-10.14
ovhtb743 m7t
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
20FR12B/A
EX-10.9
hbjhrc8
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am